Article Versions Notes

Zurl C, Waller M, Schwameis F, Muhr T, Bauer N, Zollner-Schwetz I, Valentin T, Meinitzer A, Ullrich E, Wunsch S, et al. Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations. Journal of Fungi. 2020; 6(2):90. https://doi.org/10.3390/jof6020090

Zurl, Christoph, Maximilian Waller, Franz Schwameis, Tina Muhr, Norbert Bauer, Ines Zollner-Schwetz, Thomas Valentin, Andreas Meinitzer, Elisabeth Ullrich, Stefanie Wunsch, and et al. 2020. "Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations" Journal of Fungi 6, no. 2: 90. https://doi.org/10.3390/jof6020090

Zurl, C., Waller, M., Schwameis, F., Muhr, T., Bauer, N., Zollner-Schwetz, I., Valentin, T., Meinitzer, A., Ullrich, E., Wunsch, S., Hoenigl, M., Grinschgl, Y., Prattes, J., Oulhaj, A., & Krause, R. (2020). Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations. Journal of Fungi, 6(2), 90. https://doi.org/10.3390/jof6020090